Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Buy
2,527
+48
+2% +$5.62K ﹤0.01% 91
2026
Q1
$298K Buy
2,479
+40
+2% +$4.62K ﹤0.01% 89
2025
Q4
$257K Sell
2,439
-10
-0.4% -$939 ﹤0.01% 93
2025
Q3
$206K Buy
+2,449
New +$202K ﹤0.01% 99

Other funds holding MRK

Acorns Advisers's MRK Position: Q2 2026 in Review

Acorns Advisers increased its Merck (MRK) stake by 1.9% in Q2 2026, buying an estimated $5.62K and bringing the position to 2,527 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #91.

Acorns Advisers first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Acorns Advisers held 2,527 shares of Merck worth $325K as of Q2 2026.
  • Acorns Advisers bought 48 Merck shares in Q2 2026, an estimated $5.62K.
  • Merck made up ﹤0.01% of Acorns Advisers's portfolio in Q2 2026, its #91 holding.
  • Acorns Advisers first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Acorns Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.